Anticancer Therapeutics

• Includes information on the emerging therapeutics currently in various stages of clinical trials including chemical and crystal structures.
• Multidisciplinary approach to the subject with discussion of development of resistance, design of new drugs and overview of their pharmacological properties in conjunction with current and emerging therapeutics.
• Clear presentation of different groups of molecular cancer therapy in a single volume to enable comparison of the current with the developmental.
• Includes contributions from both academic and industrial researchers in the field to ensure a broad and balanced overview of the subject.
• Includes contributions from those currently working in drug development in association with the pharmaceutical industry and biotech spin-off companies.
• A unique approach to the subject- existing texts in the fields focus either on the anticancer drug development process or the pharmacology, pharmacokinetic and pharmacodynamic studies of anticancer drugs.
• Modern drug discovery aspects are discussed, through genomic, proteomic and metabolomic approaches.
• Examines both Chemical and Biological agents.
• Clearly structured throughout including coverage of different classes of anticancer therapeutics, a description of the target (or target class) and the characteristics that make such targets appropriate for the development of anticancer agents.

From AQ:

• The book provides a comprehensive list of anticancer therapeutic categories
• It includes both small molecule chemotherapy and biological therapies
• It provides structures of molecules included
• It gives information on uses, side effects, resistance etc. on drug categories included
• It includes both established molecules and molecules currently in clinical trials that would be the Anticancer Therapeutics in the years to come
• It is written by international authorities in their particular drug categories
• It provides information on drug design, clinical trials and pharmaceutical market